The safety and efficacy of antithyroid drugs
- 22 December 2005
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Opinion on Drug Safety
- Vol. 5 (1), 107-116
- https://doi.org/10.1517/14740338.5.1.107
Abstract
Thionamides, selective inhibitors of thyroid peroxidase-mediated iodination by tyrosine residues in thyroglobulin, have been effectively used in the treatment of hyperthyroidism. The choices for initial treatment of patients with Graves’ disease differ in various countries, and many physicians around the world prefer to administer thionamide drugs as the first choice of treatment for patients with hyperthyroidism. Although some thyroidologists more often consider radioiodine to be the treatment of choice because of its safety and ease of administration, thionamides remain the mainstay of treatment in thyrotoxic children and adolescents and in hyperthyroid women during pregnancy, postpartum period and lactation. A recent study with continuous thionamide treatment for patients with Graves’ disease shows its efficacy, safety and cost-benefit properties. Further studies of the effectiveness of continuous thionamide therapy in patients with thyrotoxicosis need to be designed and implemented to determine indications for such therapy in children, adolescents and adults with diffuse toxic goiter, in particular, in those who have had recurrence of hyperthyroidism after discontinuation of one complete course of treatment.Keywords
This publication has 91 references indexed in Scilit:
- Antithyroid Drug-Induced Agranulocytosis: Special Reference to Normal White Blood Cell Count AgranulocytosisThyroid®, 2004
- Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infantsThe Journal of Pediatrics, 1996
- Single Daily Dose of Methimazole Compared to Every 8 Hours Propylthiouracil in the Treatment of HyperthyroidismSouthern Medical Journal, 1995
- Short-term treatment of Graves' disease with methimazole in high versus low dosesJournal of Internal Medicine, 1995
- Pharmacokinetic Properties and Bioavailability of MethimazoleClinical Pharmacokinetics, 1985
- Choice of Therapy for Graves' HyperthyroidismThe New England Journal of Medicine, 1984
- Long-Term Follow-up Study of Compensated Low-Dose131I Therapy for Graves' DiseaseThe New England Journal of Medicine, 1984
- High Prevalence of Transient Post-Partum Thyrotoxicosis and HypothyroidismThe New England Journal of Medicine, 1982
- Neonatal Thyroid Function after Propylthiouracil Therapy for Maternal Graves' DiseaseThe New England Journal of Medicine, 1981
- Carbimazole and the Autoimmune Response in Graves' DiseaseThe New England Journal of Medicine, 1980